malondialdehyde has been researched along with cholecystokinin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Czakó, L; Hegyi, P; Jármay, K; Lonovics, J; Marosi, E; Pap, A; Pozsár, J; Takács, T | 1 |
| An, M; Cong, B; Gou, H; Liu, L; Liu, X; Ma, C; Wen, D | 1 |
2 other study(ies) available for malondialdehyde and cholecystokinin
| Article | Year |
|---|---|
Time-course changes in pancreatic laboratory and morphologic parameters in two different acute pancreatitis models in rats.
Topics: Acute Disease; Amylases; Animals; Cholecystokinin; Disease Models, Animal; Duodenal Obstruction; Lipid Peroxidation; Male; Malondialdehyde; Organ Size; Pancreatitis; Rats; Rats, Wistar; Sincalide; Time Factors | 1994 |
Cholecystokinin-8 inhibits methamphetamine-induced neurotoxicity via an anti-oxidative stress pathway.
Topics: Animals; Cell Survival; Central Nervous System Stimulants; Chemokines, CC; Cholecystokinin; Gene Expression Regulation; HEK293 Cells; Humans; Malondialdehyde; Methamphetamine; NADPH Oxidases; Oxidative Stress; PC12 Cells; Peptide Fragments; Rats; Reactive Oxygen Species; Receptor, Cholecystokinin B; RNA, Small Interfering; Signal Transduction; Time Factors; Transfection | 2016 |